2018
DOI: 10.1177/1538574417747426
|View full text |Cite
|
Sign up to set email alerts
|

Two-Vessel Branched Stent Graft for Severely Angulated Aortic Arch Aneurysm in a Jehovah’s Witness

Abstract: Aneurysmal disease involving the origins of supra aortic vessels often requires complex open and/or endovascular repair that is not only associated with significant risk of mortality and morbidity but also often with perioperative blood loss requiring transfusion. We report a successful repair of a large thoracic aortic aneurysm (TAA) involving the aortic arch with a custom-made Bolton Relay 2-vessel branched thoracic aortic endograft in a 42-year-old Jehovah's Witness who would otherwise be very unlikely to s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…This study did not detect 30-day mortality and in-hospital deaths, which were reported by some other studies. [30][31][32][33] In this study, our midterm results were satisfactory because there were no cases of retrograde type A dissection, type 1a endoleak, and the aorta-related death-free rate at 5 years was 95.8%. However, the postoperative stroke rate reported in our study was 14% (4 out of 28), which was higher than that reported in previous studies (5% to 11.4%) with zone 0 landing TEVAR.…”
Section: Discussionmentioning
confidence: 55%
See 1 more Smart Citation
“…This study did not detect 30-day mortality and in-hospital deaths, which were reported by some other studies. [30][31][32][33] In this study, our midterm results were satisfactory because there were no cases of retrograde type A dissection, type 1a endoleak, and the aorta-related death-free rate at 5 years was 95.8%. However, the postoperative stroke rate reported in our study was 14% (4 out of 28), which was higher than that reported in previous studies (5% to 11.4%) with zone 0 landing TEVAR.…”
Section: Discussionmentioning
confidence: 55%
“…This study did not detect 30-day mortality and in-hospital deaths, which were reported by some other studies. 30 , 31 , 32 , 33 …”
Section: Discussionmentioning
confidence: 99%